2016-04-19 16:07:11 UTC

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease

Application Deadline: Sept. 7, 2018
Start Date: July 1, 2019

Total Award Amount: $270,000
Term: 3 years
Number of Awards: 1
Eligible Categories: Career Development, Young Investigators

(Currently Closed: All details within apply to the 2018 grant and are subject to change. Details for the 2019 grant will be available May 2018.) 


This award provides $90,000 per year for three years (total $270,000) to a young investigator, instructor, research associate or equivalent working toward independent careers in gastroenterology, hepatology or related areas.



The objective of the AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease (IBD) is to support young gastroenterologists working toward independent and productive research careers in IBD by ensuring that a major proportion of their time is protected for research (i.e. a minimum of 75 percent effort dedicated to the proposed project). The award will support young faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research. 



  • Candidates for this award must hold an MD, PhD or equivalent degree (e.g. MB, ChB, MBBS, DO) and a full-time faculty position at a North American institution by the start date of this award.
    • MD (or equivalent): No more than seven years shall have elapsed following the completion of clinical training (GI fellowship or its equivalent) and the start date of this award.
    • PhD (or equivalent): No more than seven years shall have elapsed following the awarding of the PhD degree and the start date of this award.
    • An appropriately documented parental leave of absence will not be counted toward the above seven-year eligibility criteria. Exceptional circumstances may also be considered. Exemption requests must be submitted to AGA via e-mail (awards@gastro.org) as soon as possible, at minimum three weeks prior to the application deadline, and clearly indicated in submitted application documents.
  • Candidates must be an AGA member in good standing at the time of application submission. AGA membership must be maintained throughout the three-year duration of the award. Please visit www.gastro.org or call 301-654-2055, extension 651, for membership information.
  • Women and under-represented minorities are encouraged to apply.
  • Physician-scientist investigators and candidates interested in translational research are especially encouraged to apply for this award.



  • Resources allocated through this award are intended to support the career development of the applicant. The applicant must allocate a minimum of 75 percent effort on the proposed project.
    • Allowable Costs:
      • Applicants may request up to $70,000 per year for support of their own salary and benefits.
      • Up to $20,000 per year can be requested for other research expenditures such as supplies, equipment, and travel.
      • Travel expenses cannot exceed $1,500 per year.
      • Equipment expenses cannot exceed $5,000 per year.
    • Unallowable Costs:
      • Indirect costs are not allowed.
      • Requests for salary, fringe benefits or other support for the mentor are not allowed.
    • Any deviation from these budget guidelines must be clearly addressed in the budget justification and other relevant supporting documents.
  • Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee for use of human subjects or animals. If approval is not necessary, the recipient must provide an explanation. Evidence for developing independence in research initiatives should be provided.
  • Candidates are required to have a sponsor and preceptor for the award; however, one individual may serve in the capacity of both positions. A sponsor is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A preceptor will supervise the principal investigator’s research activities and will serve as a mentor.
  • Awardees must submit a progress report to the AGA annually, as well as a final report 60 days after the end date of the grant period. The report template and instructions are provided to awardees at the time of acceptance. Second and third year funding are contingent upon the submission and accuracy of this documentation.
  • All publications, presentations and abstracts arising from work funded by this program must acknowledge support of the AGA–Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease.



  • At the time of application submission, candidates may not hold or have held an NIH K01, K08, K23, K99, R00, R01, R21, R29, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (such as the American Liver Foundation, Burroughs Welcome Fund, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation, etc.). Candidates with an active K12 may apply. If a candidate is granted the award and notified of a comparable award from another agency prior to the first payment of this award, the recipient must select one of the two awards (i.e. the recipient may not retain both awards).  If the recipient is notified that a comparable award has been granted after the first payment of this award, the recipient may retain 50 percent of the AGA award. AGA must be notified by the recipient via email (awards@gastro.org) within two weeks of receiving notification of additional funding.
  • The intent of this award is to foster the scientific independence of junior investigators. Candidates whose research activities become incorporated into a grant application from a senior mentor will need to delineate clearly the scientific and experimental distinctions between their respective programs. This requirement applies both to pending applications submitted prior to review of this award and to applications submitted during the term of the RSA. It also must be clearly stated that the work submitted by the applicant is that of the applicant and not the senior mentor(s). 
  • Applicants may not submit the same project to multiple RSA categories offered within the same year.



There must be a strong commitment from the candidate’s institution to support the required protected time for research and adequate laboratory space and/or other supporting facilities. These commitments must be outlined in a letter from the candidate’s Division Chief/Department Chair. The letter must certify that the award is being used to provide protected time, in accord with the terms of the award. In addition, it is expected that the sponsor will outline specific plans for the future development of the candidate’s research career. The institution must commit to ensuring timely and accurate reporting of the awardee’s current and future research activities at the institution; this is to include verifying the funding status, grants submitted and pending, and all publications at regular intervals via progress reports required to be submitted annually to AGA.



The recipient will be selected based on the following criteria: significance, investigator, innovation, approach, environment, relevance to AGA’s mission, and evidence of institutional commitment. The candidate should state clearly how the additional training will benefit his/her research career.



A selection committee comprised of members of the AGA Research Awards Panel will review the proposals and select the award recipients. Funding will commence July 2018.



The application deadline is Sept. 8, 2017. Applications must be submitted through the AGA Grants Management System accessible at http://www.gastro.org/research-funding. Application materials will not be accepted via mail, fax, or email.  Select the “Apply Now” button to create an account and/or submit an application. If you have questions, please send an email to awards@gastro.org.


Funding for this award is provided by Takeda Pharmaceuticals U.S.A. Inc.

More on IBD

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Feb. 7, 2019

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.